Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Inoue, K., Hisatomi, A., Umeda, F
Alterations of the gut Microbiota in patients with severe chronic heart failure
Retrieved 2 June 2025
This randomized double blind placebo controlled study suggests resistant fibers may help support GLP-1 and PYY signaling
A peptides detection window is different from how long it remains active
Several methods are introduced to increase the half-life of GLP-1 including: (i) modifying peptides to make them resistant to cleavage by DPP-4, such as exenatide twice daily and lixisenatide, (ii) attaching free fatty acid side chains to liraglutide and semaglutide, which enhances their binding to plasma albumin thereby preventing renal filtration of GLP-1 and prolonging their action in vivo [36, 37], (iii) conjugation of albumin or the Fc fragment of IgG to GLP-1 molecule is used in albiglutide and dulaglutide [37, 38], (iv) development of modified nanoparticles for the controlled release of exenatide-LAR (long-acting release) that provide prolonged release of the peptide [39], and finally, (v) chemical permeation enhancers such as sodium salcaprozate (SNAC) could be utilized to overcome the low permeability and high enzymatic degradation of the gastrointestinal tract of GLP-1 analog that is administrated orally such as semaglutide [40]
US$ 22.28
US$ 29.22
US$ 28.03
US$ 23.60
US$ 20.90
US$ 29.64
US$ 22.88
US$ 25.25
US$ 28.72
US$ 21.60
